Related Experiment Video
Updated: Dec 5, 2025

Author Spotlight: Advancements and Challenges in β-Cells Differentiation from Pluripotent Stem Cells
Published on: February 2, 2024
SPARC promotes insulin secretion through down-regulation of RGS4 protein in pancreatic β cells
Li Hu1,2,3, Fengli He1,2,3, Meifeng Huang1,2,3
1Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Abstract:
SPARC-deficient mice have been shown to exhibit impaired glucose tolerance and insulin secretion, but the underlying mechanism remains unknown. Here, we showed that SPARC enhanced the promoting effect of Muscarinic receptor agonist oxotremorine-M on insulin secretion in cultured mouse islets. Overexpression of SPARC down-regulated RGS4, a negative regulator of β-cell M3 muscarinic receptors. Conversely, knockdown of SPARC up-regulated RGS4 in Min6 cells. RGS4 was up-regulated in islets from sparc -/- mice, which correlated with decreased glucose-stimulated insulin secretion (GSIS). Furthermore, inhibition of RGS4 restored GSIS in the islets from sparc -/- mice, and knockdown of RGS4 partially decreased the promoting effect of SPARC on oxotremorine-M-stimulated insulin secretion. Phosphoinositide 3-kinase (PI3K) inhibitor LY-294002 abolished SPARC-induced down-regulation of RGS4. Taken together, our data revealed that SPARC promoted GSIS by inhibiting RGS4 in pancreatic β cells.
Insights
SPARC protein aids insulin secretion by regulating RGS4, a key factor in pancreatic beta cells. This finding offers new insights into glucose regulation and potential therapeutic targets for diabetes.
Area of Science:
- Endocrinology
- Molecular Biology
- Metabolic Research
Background:
- SPARC deficiency impairs glucose tolerance and insulin secretion.
- The precise mechanism behind SPARC's role in insulin secretion is not fully understood.
Purpose of the Study:
- To elucidate the mechanism by which SPARC influences insulin secretion.
- To investigate the relationship between SPARC, RGS4, and glucose-stimulated insulin secretion (GSIS).
Main Methods:
- Studied SPARC's effect on insulin secretion in cultured mouse islets and Min6 cells.
- Analyzed the regulation of RGS4 by SPARC using overexpression and knockdown techniques.
- Investigated the role of RGS4 inhibition and PI3K signaling in SPARC-mediated effects.
Main Results:
- SPARC enhanced oxotremorine-M-stimulated insulin secretion.
- SPARC overexpression down-regulated RGS4, while SPARC deficiency up-regulated RGS4 in islets.
- Inhibition of RGS4 restored GSIS in SPARC-deficient islets.
- PI3K inhibition blocked SPARC-induced RGS4 down-regulation.
Conclusions:
- SPARC promotes glucose-stimulated insulin secretion (GSIS) by inhibiting RGS4 in pancreatic beta cells.
- This mechanism involves the phosphoinositide 3-kinase (PI3K) signaling pathway.
Related Concept Videos
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Insulin Secretory Vesicles
Cell Specific Gene Expression
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Insulin: The Receptor and Signaling Pathways
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

